Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy

Iterum Therapeutics PE Ratio 2017-2018 | ITRM

Current and historical p/e ratio for Iterum Therapeutics (ITRM) from 2017 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Iterum Therapeutics PE ratio as of January 18, 2019 is 0.00.
Iterum Therapeutics PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-01-18 5.95 inf
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.083B $0.001B
Iterum Therapeutics plc is a clinical-stage pharmaceutical company. It develops and markets therapies to address unmet medical needs, as well as provides anti-infectives to treat multi-drug resistant pathogens. The company's product pipeline consists of uncomplicated urinary tract infections, complicated urinary tract infections and complicated intra abdominal infections. Iterum Therapeutics plc is based in Dublin, Ireland.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $40.641B 27.83
Takeda Pharmaceutical (TAK) Japan $30.903B 14.44
Grifols (GRFS) Spain $13.311B 16.13
Neurocrine Biosciences (NBIX) United States $8.300B 1830.60
Nektar Therapeutics (NKTR) United States $7.997B 11.46
Ionis Pharmaceuticals (IONS) United States $7.983B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.786B 11.17
Tilray (TLRY) United States $7.192B 0.00
Loxo Oncology (LOXO) United States $7.149B 0.00
Sage Therapeutics (SAGE) United States $6.554B 0.00
Catalent (CTLT) United States $5.177B 21.71
United Therapeutics (UTHR) United States $5.045B 8.25
FibroGen (FGEN) United States $4.480B 0.00
TESARO (TSRO) United States $4.126B 0.00
Impax Laboratories (AMRX) United States $3.708B 19.71
Taro Pharmaceutical Industries (TARO) Israel $3.700B 13.70
USANA Health Sciences (USNA) United States $2.853B 24.28
Endo (ENDP) Ireland $2.176B 3.33
Heron Therapeutics (HRTX) United States $2.109B 0.00
Aerie Pharmaceuticals (AERI) United States $2.000B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.989B 0.00
Xencor (XNCR) United States $1.892B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.848B 0.00
Zogenix (ZGNX) United States $1.811B 0.00
Portola Pharmaceuticals (PTLA) United States $1.762B 0.00
PTC Therapeutics (PTCT) United States $1.738B 0.00
Corcept Therapeutics (CORT) United States $1.725B 25.32
Pacira Pharmaceuticals (PCRX) United States $1.646B 222.44
Theravance Biopharma (TBPH) Cayman Islands $1.508B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.494B 21.01
Arrowhead Pharmaceuticals (ARWR) United States $1.339B 0.00
TherapeuticsMD (TXMD) United States $1.216B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.166B 0.00
Esperion Therapeutics (ESPR) United States $1.154B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.030B 0.00
Tricida (TCDA) United States $0.925B 0.00
Radius Health (RDUS) United States $0.797B 0.00
ImmunoGen (IMGN) United States $0.760B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.644B 0.00
ChemoCentryx (CCXI) United States $0.629B 49.80
Karyopharm Therapeutics (KPTI) United States $0.599B 0.00
Siga Technologies (SIGA) United States $0.590B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.553B 0.00
Flexion Therapeutics (FLXN) United States $0.552B 0.00
Collegium Pharmaceutical (COLL) United States $0.524B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.484B 28.55
GlycoMimetics (GLYC) United States $0.466B 0.00
Odonate Therapeutics (ODT) United States $0.457B 0.00
Forty Seven (FTSV) United States $0.450B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.431B 0.00
ArQule (ARQL) United States $0.408B 0.00
Akebia Therapeutics (AKBA) United States $0.365B 0.00
Majesco Entertainment (PTE) United States $0.358B 0.00
Xeris Pharmaceuticals (XERS) United States $0.355B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.348B 0.00
CASI Pharmaceuticals (CASI) United States $0.347B 0.00
Concert Pharmaceuticals (CNCE) United States $0.333B 0.00
Lannett Co Inc (LCI) United States $0.300B 2.60
OptiNose (OPTN) United States $0.296B 0.00
KalVista Pharmaceuticals (KALV) United States $0.288B 0.00
Dermira (DERM) United States $0.286B 0.00
Minerva Neurosciences (NERV) United States $0.275B 0.00
Tapimmune (MRKR) United States $0.272B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.269B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.268B 0.00
Depomed (ASRT) United States $0.267B 9.95
IMV INC (IMV) Canada $0.264B 0.00
Aclaris Therapeutics (ACRS) United States $0.260B 0.00
Mast Therapeutics (SVRA) United States $0.259B 0.00
Translate Bio (TBIO) United States $0.250B 0.00
Tyme Technologies (TYME) United States $0.249B 0.00
Opexa Therapeutics (ACER) United States $0.243B 0.00
Aldeyra Therapeutics (ALDX) United States $0.234B 0.00
Dova Pharmaceuticals (DOVA) United States $0.232B 0.00
TAIWAN LIPOSOME (TLC) Taiwan $0.230B 0.00
Affimed (AFMD) Germany $0.221B 0.00
Aratana Therapeutics (PETX) United States $0.215B 0.00
Rafael Holdings (RFL) United States $0.207B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.201B 0.00
Galectin Therapeutics (GALT) United States $0.195B 0.00
MEI Pharma (MEIP) United States $0.194B 0.00
Zafgen (ZFGN) United States $0.175B 0.00
Aquestive Therapeutics (AQST) United States $0.173B 0.00
Recro Pharma (REPH) United States $0.172B 0.00
Calithera Biosciences (CALA) United States $0.170B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.165B 0.00
Ocular Therapeutix (OCUL) United States $0.163B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.155B 0.00
Molecular Templates (MTEM) United States $0.155B 0.00
Nature's Sunshine Products (NATR) United States $0.154B 0.00
ElectroCore (ECOR) United States $0.148B 0.00
Redhill Biopharma (RDHL) Israel $0.147B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.147B 0.00
Adherex Technologies (FENC) United States $0.139B 0.00
Ardelyx (ARDX) United States $0.139B 0.00
Neon Therapeutics (NTGN) United States $0.138B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.136B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.135B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.131B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.130B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.126B 0.00
Jounce Therapeutics (JNCE) United States $0.124B 0.00
MediWound (MDWD) Israel $0.118B 0.00
Cardiome Pharma (CORV) Canada $0.115B 0.00
Champions Oncology (CSBR) United States $0.115B 0.00
ProNAi Therapeutics (SRRA) Canada $0.108B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.104B 0.00
Aptorum Group (APM) China $0.095B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.094B 0.00
DURECT (DRRX) United States $0.094B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.091B 0.00
Natural Alternatives (NAII) United States $0.083B 8.18
Nivalis Therapeutics (ALPN) United States $0.079B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.074B 0.00
CTI BioPharma (CTIC) United States $0.071B 0.00
Infinity Pharmaceuticals (INFI) United States $0.071B 0.00
Avenue Therapeutics (ATXI) United States $0.070B 0.00
KemPharm (KMPH) United States $0.070B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.069B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.069B 0.00
Immune Design (IMDZ) United States $0.068B 0.00
Otonomy (OTIC) United States $0.062B 0.00
BioLineRx (BLRX) Israel $0.062B 0.00
Neos Therapeutics (NEOS) United States $0.061B 0.00
Achaogen (AKAO) United States $0.060B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.058B 0.00
Melinta Therapeutics (MLNT) United States $0.057B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.056B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.054B 0.00
Genocea Biosciences (GNCA) United States $0.051B 0.00
Forward Pharma (FWP) Denmark $0.050B 0.00
Mannatechorporated (MTEX) United States $0.046B 0.00
ContraFect (CFRX) United States $0.044B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.043B 0.00
Capnia (SLNO) United States $0.036B 0.00
NOVAN INC (NOVN) United States $0.036B 0.00
Lipocine (LPCN) United States $0.036B 0.00
SCYNEXIS (SCYX) United States $0.036B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
Heat Biologics (HTBX) United States $0.032B 0.00
IsoRay (ISR) United States $0.028B 0.00
PharmAthene (ALT) United States $0.025B 0.00
ESSA Pharma (EPIX) Canada $0.025B 0.00
Trillium Therapeutics (TRIL) Canada $0.025B 0.00
Can-Fite Biopharma (CANF) Israel $0.024B 0.00
Biomerica (BMRA) United States $0.022B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.022B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.021B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.020B 0.00
Citius Pharmaceuticals (CTXR) United States $0.020B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.020B 0.00
Pain Therapeutics (PTIE) United States $0.019B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.019B 0.00
Xenetic Biosciences (XBIO) United States $0.019B 0.00
HANCOCK JAFFE (HJLI) United States $0.019B 0.00
NanoViricides (NNVC) United States $0.018B 0.00
Cyanotech (CYAN) United States $0.018B 0.00
Jaguar Animal Health (JAGX) United States $0.018B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.016B 0.00
Aviragen Therapeutics (VXRT) United States $0.014B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.014B 0.00
Skyline Medical (AIPT) United States $0.013B 0.00
Shineco (TYHT) China $0.012B 1.27
Onconova Therapeutics (ONTX) United States $0.011B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Regulus Therapeutics (RGLS) United States $0.010B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.009B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.007B 0.00
Apricus Biosciences (APRI) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.005B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.004B 0.00
Bio Blast Pharma (ORPN) Israel $0.003B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.003B 0.00
Intellipharmaceutics (IPCI) Canada $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.001B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
AGEX THERAPEUTC (AGE) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00